Published by Iain Gilbert on 6th November 2025
(Sharecast News) - Drugmaker AstraZeneca reiterated its full-year guidance on Thursday as it posted a third-quarter earnings beat, driven by solid sales of its cancer, heart and kidney disease drugs.
URL: http://www.digitallook.com/dl/news/story/35476708/...